Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics
ADPTAdaptive Biotechnologies(ADPT) Zacks Investment Research·2024-05-08 08:30

Adaptive Biotechnologies (ADPT) reported 41.87millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof11.241.87 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 11.2%. EPS of -0.33 for the same period compares to -0.40ayearago.Thereportedrevenuerepresentsasurpriseof−0.780.40 a year ago. The reported revenue represents a surprise of -0.78% over the Zacks Consensus Estimate of 42.2 million. With the consensus EPS estimate being -$0.35, the EPS surprise was +5.71%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectat ...